Intensified Chemotherapy in CRC After Resection of Liver Metastases

StatusCompleted
PhasePhase 2/3
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study Status, Referencesv4
  2. Re-verified, no change to tracked fieldsv3
  3. Enrollment target: 300 to 124v2 Show 7 more changesShow less
    • Trial status: Recruiting to Completed
    • Study completion date: Aug 2007
    • Interventions: 5FU/AF (Drug), Irinotecan (Drug), Oxaliplatin (Drug) to FOLFIRI (Drug), FOLFIRI-HD (Drug), FOLFIRINOX (Drug), FOLFOX-4 (Drug), FOLFOX-7 (Drug)
    • Secondary endpoints: 2 to 3
    • Site details revised
    • Collaborators: 1 to 3
    • Study arms: 0 to 5
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Randomized, open label, multicentre phase II trial followed by phase III comparing overall survival after having selected the best experimental arm.
Trial Details
NCT Number NCT00208260
Lead Sponsor Institut du Cancer de Montpellier - Val d'Aurelle
Collaborators: Pfizer, Sanofi, Chugai Pharmaceutical
Conditions
(from sponsor)		 Colorectal Cancer, Liver Metastases, Chemotherapy
Related terms Colorectal Neoplasms
Enrollment 124 participants
Start Date
Study Completion (estimated)
Updated on ClinicalTrials.gov